Follow up protocol (after surgical removal of cholangiocarcinoma)

Discussion Forum Discussion Forum Clinical Trials and Treatments Follow up protocol (after surgical removal of cholangiocarcinoma)

This topic contains 0 replies, has 1 voice, and was last updated by  Helen_ammf 6 months ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #13319

    Helen_ammf
    Moderator

    Many thanks to Roz, one of AMMF’s Forum posters for asking a very important question about follow-up after surgery for cholangiocarcinoma (bile duct cancer). The following details are given in a reply within that conversation thread, but we thought it would be useful for everyone to have them in an area where they could be readily seen. So here they are:

    ESMO* did set some follow-up guidelines in their paper published in September 2016, ‘Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’, which AMMF reviewed for ESMO. This is the relevant section from those guidelines:

    “Follow-up and long-term implications
    Follow-up after potentially curative treatment should consist of 3-monthly visits during the first 2 years after therapy including clinical examination, laboratory investigation (including LFTs and lactate dehydrogenase), tumour markers (carcinoembryonic antigen, CA19-9) and CT scan of the thorax, abdomen and pelvis [IV, A]. Regular visits can be extended to 6-monthly thereafter and prolonged to yearly visits after 5 years of follow-up.”

    This is the link to the full paper:
    https://doi.org/10.1093/annonc/mdw324

    *ESMO: European Society for Medical Oncology

    Please note: it is not appropriate for AMMF to give medical advice or recommendations, and all details provided are for information purposes only.

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.